- Stocks
- Healthcare
- NASDAQ: SNTI

Price (delayed)

$2.355

Market cap

$10.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$14.4

Enterprise value

$19.75M

SNTI's EPS is up by 24% year-on-year and by 10% since the previous quarter

SNTI's net income is up by 9% from the previous quarter

SNTI's gross profit has dropped by 71% year-on-year and by 50% since the previous quarter

The revenue has plunged by 71% YoY and by 50% from the previous quarter

What are the main financial stats of SNTI

Market
Valuations
Earnings

Shares outstanding

4.58M

Market cap

$10.78M

Enterprise value

$19.75M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.19

Price to sales (P/S)

8.44

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

15.49

Revenue

$1.28M

EBIT

-$64.45M

EBITDA

-$58.49M

Free cash flow

-$53.21M

Per share
Balance sheet
Liquidity

EPS

-$14.4

Free cash flow per share

-$11.64

Book value per share

$12.26

Revenue per share

$0.28

TBVPS

$22.36

Total assets

$102.19M

Total liabilities

$46.09M

Debt

$36.72M

Equity

$56.09M

Working capital

$46.06M

Debt to equity

0.65

Current ratio

5.79

Quick ratio

2.9

Net debt/EBITDA

-0.15

Margins
Efficiency
Dividend

EBITDA margin

-4,587.1%

Gross margin

100%

Net margin

-5,054.7%

Operating margin

-7,726.3%

Return on assets

-51.9%

Return on equity

-85%

Return on invested capital

-57.2%

Return on capital employed

-69.6%

Return on sales

-5,054.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Senti Biosciences stock price performed over time

Intraday

-2.28%

1 week

659.68%

1 month

805.77%

1 year

164.31%

YTD

256.82%

QTD

741.07%

How have Senti Biosciences's revenue and profit performed over time

Revenue

$1.28M

Gross profit

$1.28M

Operating income

-$98.51M

Net income

-$64.45M

Gross margin

100%

Net margin

-5,054.7%

Senti Biosciences's operating margin has shrunk by 113% QoQ

The net margin has plunged by 82% from the previous quarter

SNTI's gross profit has dropped by 71% year-on-year and by 50% since the previous quarter

The revenue has plunged by 71% YoY and by 50% from the previous quarter

What is Senti Biosciences's growth rate over time

What is Senti Biosciences stock price valuation

P/E

N/A

P/B

0.19

P/S

8.44

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

15.49

SNTI's EPS is up by 24% year-on-year and by 10% since the previous quarter

Senti Biosciences's equity has shrunk by 50% YoY and by 16% QoQ

SNTI's P/B is 33% below its last 4 quarters average of 0.3

The revenue has plunged by 71% YoY and by 50% from the previous quarter

The P/S is 11% less than the last 4 quarters average of 9.7

How efficient is Senti Biosciences business performance

SNTI's return on sales has dropped by 82% since the previous quarter

The ROE has plunged by 74% YoY and by 8% from the previous quarter

The ROA has contracted by 46% YoY

What is SNTI's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for SNTI.

How did Senti Biosciences financials performed over time

The company's total assets is 122% higher than its total liabilities

The quick ratio has dropped by 54% year-on-year and by 7% since the previous quarter

The company's total assets fell by 37% YoY and by 14% QoQ

The debt is 35% less than the equity

SNTI's debt to equity has surged by 91% year-on-year and by 16% since the previous quarter

Senti Biosciences's equity has shrunk by 50% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.